{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Recovery News | Mental Health & Addiction Recovery","title":"Twelve Hundred Patients, One Weekly Shot: The Mega-Trial Testing Semaglutide for Addiction","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/65139381\"></iframe>","width":"100%","height":180,"duration":242,"description":"Twelve Hundred Patients, One Weekly Shot: The Mega-Trial Testing Semaglutide for Addiction\nFunded by a $13.3 million Arnold Ventures grant, researchers at the University of Pittsburgh and Allegheny County will test once-weekly semaglutide, added to standard care for 52 weeks, in up to 1,200 adults with alcohol use disorder, opioid use disorder, or both — tracking employment, housing and criminal-justice outcomes alongside substance use.\nSource\nMajor trial seeks to test semaglutide on adults with alcohol and opioid use disorder — News-Medical (Oct 13, 2026), reporting on the trial led by the Center for Addiction Science, Policy, and Research (CASPR), University of Pittsburgh, with the Allegheny County Department of Human Services.","thumbnail_url":"https://img.transistorcdn.com/1HMwgudOv-9iLP25S2rFy3To1lXT_m4L2ceV1SNYp_k/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83NWQ4/NzUyZmIxMzg4YjVk/YzI2NWVkOGVkYmQ0/NzBkOC5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}